Yuan Ma

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A Folded, Structure-Integrated Bimodal Sensor Enabling Non-Contact and Tactile Perception for Intelligent Robots.

A Folded, Structure-Integrated Bimodal Sensor Enabling Non-Contact and Tactile Perception for Intelligent Robots.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 30, 2026

Blocking interaction of sclerostin loop3 with osteoblastic LRP4 counteracts bone loss without increasing arterial stiffness during mechanical unloading.

Blocking interaction of sclerostin loop3 with osteoblastic LRP4 counteracts bone loss without increasing arterial stiffness during mechanical unloading.

Journal: Journal of orthopaedic translation

Published: December 23, 2025

AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophy.

AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophy.

Journal: Acta pharmaceutica Sinica. B

Published: August 11, 2025

Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders.

Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders.

Journal: JACS Au

Published: July 06, 2025

Peptide Aptamer-Paclitaxel Conjugates for Tumor Targeted Therapy.

Peptide Aptamer-Paclitaxel Conjugates for Tumor Targeted Therapy.

Journal: Pharmaceutics

Published: November 13, 2024

Developing Stapled Aptamers with a Constrained Conformation for Osteogenesis Imperfect Therapeutics.

Developing Stapled Aptamers with a Constrained Conformation for Osteogenesis Imperfect Therapeutics.

Journal: Journal of medicinal chemistry

Published: October 29, 2024

Advancing Design Strategy of PROTACs for Cancer Therapy.

Advancing Design Strategy of PROTACs for Cancer Therapy.

Journal: MedComm

Published: October 15, 2024

DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning model.

DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning model.

Journal: Molecular therapy. Nucleic acids

Published: August 02, 2024

Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release.

Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release.

Journal: Journal of translational medicine

Published: March 19, 2024

Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity.

Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity.

Journal: Nature communications

Published: March 16, 2024

Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy.

Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy.

Journal: Cancer letters

Published: February 23, 2024

Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives.

Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives.

Journal: Journal of orthopaedic translation

Published: December 28, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026